KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Operating Leases (2020 - 2024)

Clover Health Investments' Operating Leases history spans 5 years, with the latest figure at $2.3 million for Q3 2024.

  • For Q3 2024, Operating Leases fell 29.5% year-over-year to $2.3 million; the TTM value through Sep 2024 reached $2.3 million, down 29.5%, while the annual FY2023 figure was $3.0 million, 25.66% down from the prior year.
  • Operating Leases reached $2.3 million in Q3 2024 per CLOV's latest filing, down from $2.5 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $9.3 million in Q2 2021 to a low of $2.3 million in Q3 2024.
  • Average Operating Leases over 5 years is $4.3 million, with a median of $4.0 million recorded in 2022.
  • The largest YoY upside for Operating Leases was 11.44% in 2022 against a maximum downside of 50.52% in 2022.
  • A 5-year view of Operating Leases shows it stood at $6.3 million in 2020, then dropped by 23.93% to $4.8 million in 2021, then decreased by 16.5% to $4.0 million in 2022, then fell by 25.66% to $3.0 million in 2023, then fell by 22.58% to $2.3 million in 2024.
  • Per Business Quant, the three most recent readings for CLOV's Operating Leases are $2.3 million (Q3 2024), $2.5 million (Q2 2024), and $2.7 million (Q1 2024).